PMID: 29770001Feb 4, 2016Paper

Benzathine penicillin G for the management of early syphilis among HIV co-infected persons: A systematic review

Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada
O NiragiraA Singh

Abstract

The optimal treatment for syphilis in people who are human immunodeficiency virus (HIV) positive is controversial. To assess the efficacy of three doses versus a single dose of long acting Benzathine Penicillin G (BP-G) for the effective management of early syphilis among HIV co-infected populations. A systematic search of the published literature was conducted using MEDLINE and EMBASE databases to identify clinical and observational studies published between January 2010 and May 2015. Inclusion criteria were: publication in English or French, populations co-infected with HIV and early syphilis, treatment with BP-G and outcomes related to syphilis treatment. All articles underwent a risk of bias assessment and data extraction was completed on all included studies. Seven studies were eligible for final inclusion, data extraction and analysis. The evidence from the final included studies were from non-randomized controlled trials. In general, no significant differences were found between groups treated with one versus two or more doses of BP-G; but there was a trend toward longer time to treatment failure with three doses. Differences in methodology limit the ability to draw any firm conclusions on the relative efficacy between t...Continue Reading

References

Sep 18, 2003·JAMA : the Journal of the American Medical Association·Matthew R GoldenKing K Holmes
Jan 28, 2004·The Journal of Infectious Diseases·Christina M MarraScott H Barnett
Jun 21, 2005·Infectious Disease Clinics of North America·Kevin A Fenton, John Imrie
Jan 16, 2007·Lancet·Zhi-Qiang ChenMyron S Cohen
Apr 5, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nicola M Zetola, Jeffrey D Klausner
Aug 28, 2010·Clinics in Dermatology·David Farhi, Nicolas Dupin
Oct 7, 2010·Sexually Transmitted Infections·Leah J BlankKhalil G Ghanem
Aug 19, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Frédéric Frippiat, Michel Moutschen
Dec 3, 2011·The Journal of Clinical Investigation·Anne Rompalo
Feb 1, 2012·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Eric Macy, Ngoc J Ho
Sep 4, 2012·American Journal of Obstetrics and Gynecology·Amy E WongMardge H Cohen
Sep 8, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Damaris Fröhlich KnautePhilipp P Bosshard
Oct 4, 2012·International Journal of STD & AIDS·E G MuldoonF Mulcahy
Jan 4, 2013·Bulletin of the World Health Organization·Grace Wu, Muhammad H Zaman
Mar 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jodie Dionne-OdomSusan Allen
Jun 15, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marc M SolomonUNKNOWN iPrEx Study Team
Nov 12, 2014·JAMA : the Journal of the American Medical Association·Meredith E ClementCharles B Hicks
Nov 13, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anuradha GanesanUNKNOWN Infectious Disease Clinical Research Program HIV/STI Working Group
Nov 28, 2014·Clinical and Vaccine Immunology : CVI·Muhammad G Morshed, Ameeta E Singh
Jun 28, 2015·BMJ : British Medical Journal·Susan Mayor

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Roberto AndradeJose A Serpa
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
I NikolopoulosW Atiomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Anuradha GanesanInfectious Disease Clinical Research Program HIV/STI Working Group
© 2022 Meta ULC. All rights reserved